Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP670176.RA1WO4eAGjjmce-72hZlyz_LlA5hX3s5RL95b3r5rgmM0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP670176.RA1WO4eAGjjmce-72hZlyz_LlA5hX3s5RL95b3r5rgmM0130_assertion type Assertion NP670176.RA1WO4eAGjjmce-72hZlyz_LlA5hX3s5RL95b3r5rgmM0130_head.
- NP670176.RA1WO4eAGjjmce-72hZlyz_LlA5hX3s5RL95b3r5rgmM0130_assertion description "[One hundred and forty-five patients aged 0-17 at diagnosis (54% African American, 22% Caucasian, 16% Latino, 8% mixed-other) were studied at mean duration 6.9 � 5.7 (range 0.1-28.5) yr, including human leukocyte antigen (HLA)-DQA1-DQB1 genotyping, stimulated C peptide (CP), glutamic acid decarboxylase, and insulinoma-associated antigen 2 antibodies (ABs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP670176.RA1WO4eAGjjmce-72hZlyz_LlA5hX3s5RL95b3r5rgmM0130_provenance.
- NP670176.RA1WO4eAGjjmce-72hZlyz_LlA5hX3s5RL95b3r5rgmM0130_assertion evidence source_evidence_literature NP670176.RA1WO4eAGjjmce-72hZlyz_LlA5hX3s5RL95b3r5rgmM0130_provenance.
- NP670176.RA1WO4eAGjjmce-72hZlyz_LlA5hX3s5RL95b3r5rgmM0130_assertion SIO_000772 21418452 NP670176.RA1WO4eAGjjmce-72hZlyz_LlA5hX3s5RL95b3r5rgmM0130_provenance.
- NP670176.RA1WO4eAGjjmce-72hZlyz_LlA5hX3s5RL95b3r5rgmM0130_assertion wasDerivedFrom befree-20140225 NP670176.RA1WO4eAGjjmce-72hZlyz_LlA5hX3s5RL95b3r5rgmM0130_provenance.
- NP670176.RA1WO4eAGjjmce-72hZlyz_LlA5hX3s5RL95b3r5rgmM0130_assertion wasGeneratedBy ECO_0000203 NP670176.RA1WO4eAGjjmce-72hZlyz_LlA5hX3s5RL95b3r5rgmM0130_provenance.